Register ~TODAY~ for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.
This free CE event is both in-person and virtual on Tues, May 26 @ 12 pm EDT @ the Charlotte Convention Center.
For more info and to register, visit: academiccme.com/precmsc26. #CE#MS#Lublin#CMSC#APP
#Hantavirus cluster linked to cruise ship travel:
Since 1 April when the boat set sail, of the 147 passengers and crew, 7 people have become ill, among whom 3 have died, 1 is critically ill and 3 are reporting mild symptoms.
Based on the current information, including how hantavirus spreads, WHO assesses the risk to the global population from this event as low.
We are working closely with health authorities from the countries involved and the ship's operators to ensure passengers and crew get the information and support they need.
WHO will continue to monitor the situation and update the risk assessment as more information becomes available.
More information bit.ly/42Tc4J7
Published today, Brain Health Across the Life Span: A Framework for Future Studies A Scientific Statement from the American Heart Association.
📷 Recommendations to optimize brain health
Combined oral contraceptives and hormone-replacement therapy increase the risk of venous thromboembolism, although the absolute risk is low. Transdermal estradiol and micronized progesterone carry lower risk.
Learn more in the Review Article “Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk” by Leslie Skeith, MD, MHPE, and Shannon M. Bates, MDCM, from @ucalgary and @mcmasteru: nejm.org/doi/full/10.1056/NE…
ALT Review Article
Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
Figure 1. Interaction between Hormones and the Coagulation, Fibrinolytic, and Vascular Systems.
Register for free Pre-CMSC Course chaired by Dr. Lublin on Tues May 26 @ 12pm ET, in-person @ Charlotte Convention Center & virtual. Info: academiccme.com/precmsc26
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.
cell.com/cell-metabolism/abs…
Register TODAY for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.
This free CE event is both in-person and virtual on Tues, May 26 @ pm EDT @ the Charlotte Convention Center.
For more info and to register, visit: academiccme.com/precmsc26. #CE#MS#Lublin#CMSC#APP
Using noninvasive tests to stage fibrosis opens the door to truly personalized MASLD and MASH care, allowing us to match lifestyle, incretin based therapies, resmetirom and standard cirrhosis management to each patient’s fibrosis stage, enabling an approach tailored to liver disease severity.
nature.com/articles/s41575-0…
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read the full review: nejm.org/doi/full/10.1056/NE…
New MASLD review by Rinella & Sookoian in @NatRevGastroHep outlines a personalized roadmap for #MASH care, integrating metabolic, liver-directed, and lifestyle therapies. With resmetirom & semaglutide available, there is opportunity for combo strategies, biomarkers & precision medicine.
nature.com/articles/s41575-0…
At CMSC, we’re committed to improving the lives of people affected by MS. This #MSAwarenessMonth, we celebrate the strength of the MS community — advancing care, research & education together. Learn more at mscare.org#MultipleSclerosis#CMSC#MSCommunity
Register TODAY for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD.
This free CE event is both in-person and virtual on Tues, May 26 @ pm EDT @ the Charlotte Convention Center. For more info and to register, visit: academiccme.com/precmsc26.
#CE#MS#Lublin#CMSC#APP
Incretin medications act via a distributed gut–brain–islet–adipose–hepatic axis. By differentially recruiting GLP‑1, GIP, glucagon, amylin, and PYY signaling across CNS, islets, adipose tissue, liver, and stomach, multi-receptor agonists modulate energy intake, energy expenditure, and glucose and lipid handling.
academic.oup.com/edrv/articl…